𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Treatment of postmenopausal osteoporosis with 1,25-dihydroxyvitamin d3

✍ Scribed by M. W. Tilyard

Publisher
Springer-Verlag
Year
1993
Tongue
English
Weight
191 KB
Volume
3
Category
Article
ISSN
0937-941X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Immunomodulatory role of 1,25-dihydroxyv
Immunomodulatory role of 1,25-dihydroxyvitamin D3
✍ Jacques M. Lemire πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 537 KB

The active vitamin D metabolite 1,25-dihydroxyvitamin D3 [1,25-D3] is thought to promote many of its actions through interaction with a specific intracellular receptor. The discovery of such receptors in monocytes and activated lymphocytes has led investigators to evaluate the role of the hormone on

Hexafluoro-1,25-dihydroxyvitamin D3 has
Hexafluoro-1,25-dihydroxyvitamin D3 has markedly increased potency in inhibiting proliferation of cultured human keratinocytes compared with 1,25-dihydroxyvitamin D3
✍ T.C. Chen; M.F. Holick πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 409 KB

## Background: Although topical 1,25-dihydroxyvitamin d3 (calcitriol, 1, 25(oh)2d3) and its analogues, calcipotriol and tacalcitol, are effective for patients with psoriasis, some patients show little or no response. there is a need to develop more potent analogues of 1, 25(oh)2d3. hexafluoro-1,25(